Covered recipient · General Payments record
ASHLEY R TORRES
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Gerontology
General Payments · PY2021–2025
$942.01
- Reported across 22 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $148.79 | 8 |
| Education | $99.99 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $99.99 | 1 |
| Janssen Biotech, Inc. | $35.17 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.96 | 1 |
| GlaxoSmithKline, LLC. | $20.77 | 1 |
| Merck Sharp & Dohme Corporation | $20.42 | 1 |
| GENZYME CORPORATION | $17.50 | 1 |
| Smith+Nephew, Inc. | $16.66 | 1 |
| Genmab U.S., Inc. | $16.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $99.99 | 04/11/2025 | Education | Undisputed | 06/30/2026 | 1206613868 | CMS |
| Genmab U.S., Inc. | $16.31 | 07/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235931447 | CMS |
| GENZYME CORPORATION | $17.50 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233672866 | CMS |
| GlaxoSmithKline, LLC. | $20.77 | 11/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191325619 | CMS |
| Janssen Biotech, Inc. | $16.45 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175177126 | CMS |
| Janssen Biotech, Inc. | $18.72 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175178290 | CMS |
| Merck Sharp & Dohme LLC | $20.42 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238063035 | CMS |
| Smith+Nephew, Inc. | $16.66 | 12/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242317854 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.96 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223780008 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.